63 related articles for article (PubMed ID: 2350993)
1. Accumulation of the risk factors of atherosclerosis in type-II diabetics with hypertension.
Tkác I; Takác M
Czech Med; 1990; 13(1):9-17. PubMed ID: 2350993
[TBL] [Abstract][Full Text] [Related]
2. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
Van Gaal L
Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
[TBL] [Abstract][Full Text] [Related]
3. [Uric acid--a risk factor or atherosclerosis marker in type 2 diabetes?].
Tkác I; Bomba J; Cvanigová A
Vnitr Lek; 1990 Aug; 36(8):763-8. PubMed ID: 2136461
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors for atherosclerosis in the early stages of diabetes].
Dvoráková L
Cas Lek Cesk; 1990 Feb; 129(5):135-8. PubMed ID: 2331728
[TBL] [Abstract][Full Text] [Related]
5. [The value of hypertension and metabolic factors on the development of coronary heart disease in type II diabetic patients].
Schmechel H; Schulze J; Hanefeld M; Julius U; Schwanebeck U; Lippold C
Z Gesamte Inn Med; 1988 Dec; 43(23):669-74. PubMed ID: 3245248
[TBL] [Abstract][Full Text] [Related]
6. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
Velussi M
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
[TBL] [Abstract][Full Text] [Related]
7. [Incidence of risk factors and vascular complications in patients with newly diagnosed type 2 diabetes mellitus].
Krahulec B; Vozár J;
Vnitr Lek; 2002 Nov; 48(11):1031-8. PubMed ID: 12577454
[TBL] [Abstract][Full Text] [Related]
8. [Factors affecting serum lipid levels in patients with type 2 diabetes mellitus].
Tkác I; Tkácová R; Molcányiová A; Mudríková T; Takác M
Vnitr Lek; 1994 Jan; 40(1):17-20. PubMed ID: 8140744
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
10. [Circadian rhythm of blood pressure and heart rate in hypertension with type 2 diabetes mellitus].
Narkiewicz K; Rynkiewicz A; Jasiel-Wojculewicz H; Bartłomiejczyk-Majchrowicz K; Bieniaszewski L; Furmański J; Krupa-Wojciechowska B
Kardiol Pol; 1993 Jul; 39(7):23-6. PubMed ID: 8411838
[TBL] [Abstract][Full Text] [Related]
11. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
Głowińska B; Urban M; Peczyńska J; Florys B
Przegl Lek; 2004; 61(9):935-9. PubMed ID: 15803902
[TBL] [Abstract][Full Text] [Related]
12. Differences between diabetic and non-diabetic hypertensive patients with first acute non-ST elevation myocardial infarction and predictors of in-hospital complications.
Colivicchi F; Mettimano M; Genovesi-Ebert A; Schinzari F; Iantorno M; Melina G; Santini M; Cardillo C; Melina D
J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):267-72. PubMed ID: 18301144
[TBL] [Abstract][Full Text] [Related]
13. [QT interval dispersion in hypertensive diabetics and in patients with hypertension with chronic heart failure without diabetes].
Radman A; Murín J; Bulas J; Reptová A; Ravingerová T; Mikes P; Kozliková K; Ghanem W; Jaber J; Baqi L
Vnitr Lek; 2003 Oct; 49(10):802-7. PubMed ID: 14682153
[TBL] [Abstract][Full Text] [Related]
14. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus.
Kanoun F; Ben Amor Z; Zouari B; Ben Khalifa F
Diabetes Metab; 2001 Dec; 27(6):695-700. PubMed ID: 11852379
[TBL] [Abstract][Full Text] [Related]
15. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
[TBL] [Abstract][Full Text] [Related]
16. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.
Colak E; Majkić-Singh N; Stanković S; Srecković-Dimitrijević V; Djordjević PB; Lalić K; Lalić N
Ann Med; 2005; 37(8):613-20. PubMed ID: 16338763
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of early-onset type 2 diabetes and risk factors associated with its chronic complications].
Zhang M; Li H; Zhang Z
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2547-51. PubMed ID: 17198563
[TBL] [Abstract][Full Text] [Related]
18. Effects of body mass index, plasma glucose and cholesterol levels on isolated systolic hypertension.
Ko GT; Cockram CS; Chow CC; Chan WB; So WY; Ma R; Osaki R; Chan JC
Int J Cardiol; 2005 Jun; 101(3):429-33. PubMed ID: 15907411
[TBL] [Abstract][Full Text] [Related]
19. [Arteriosclerosis risk factors in the offspring and siblings of type 2 diabetics].
Jirkovská A; Válek V; Skibová J; Poledne R; Petrásek R
Vnitr Lek; 1991; 37(7-8):671-7. PubMed ID: 1755208
[TBL] [Abstract][Full Text] [Related]
20. Determination of free L-carnitine levels in type II diabetic women with and without complications.
Poorabbas A; Fallah F; Bagdadchi J; Mahdavi R; Aliasgarzadeh A; Asadi Y; Koushavar H; Vahed Jabbari M
Eur J Clin Nutr; 2007 Jul; 61(7):892-5. PubMed ID: 17311064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
